Ultra-High Dose Drug Slows Functional Decline in Early ALS Ultra-High Dose Drug Slows Functional Decline in Early ALS

An ultra-high dose of methylcobalamin slows functional decline and is safe in patients with early stage amyotrophic lateral sclerosis, results from a new phase 3 study suggest.Medscape Medical News
Source: Medscape FamilyMedicine Headlines - Category: Primary Care Tags: Neurology & Neurosurgery News Source Type: news